As a Billionaire Activist Takes a Stake, Is Now the Time to Buy Pfizer Stock?

Starboard will look to turn around the struggling pharma company.Shares of Pfizer (PFE -0.07%) have been stuck in the mud since December 2022, with its shares down more than 45% over that stretch. Despite its underwhelming performance, many individual investors are attracted to the drug giant's robust dividend, with the stock now having a forward dividend yield of about 5.7%. And despite its performance, one large institutional investor just revealed a billion-dollar bet on the company.According to the Wall ...